# Tennant Co: Form 10-Q for the period ended Sep 30, 2020

- Company: [Tennant Co](/companies/tnc.md) (CIK 97134)
- Form: 10-Q
- Filed: 2020-10-29
- Accepted by EDGAR: Oct 29, 2020, 09:18 ET
- Period: 2020-09-30
- Accession: 0000097134-20-000042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97134/000009713420000042/form10-q9302020.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97134/000009713420000042/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $157.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2020-01-01 to 2020-09-30 | $428.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $104.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-01-01 to 2020-09-30 | $299.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-07-01 to 2020-09-30 | $7.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-01-01 to 2020-09-30 | $21.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $79.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $222.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | $18.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | $55.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-07-01 to 2020-09-30 | $5.2m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-30 | $15.9m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | $5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | $11.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | $31.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | $1.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.64 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-01-01 to 2020-09-30 | $1.70 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-07-01 to 2020-09-30 | 18,648,328 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-01-01 to 2020-09-30 | 18,623,967 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $97.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $25.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2020-01-01 to 2020-09-30 | $12.1m | us-gaap:PaymentsOfDividends |
| Current assets | at 2020-09-30 | $491.3m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $1.06bn | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $244.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $668.2m | us-gaap:Liabilities |
| Current portion of debt | at 2020-09-30 | $16.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2020-09-30 | $393.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 24,904 characters.

### Overview

Tennant Company is a world leader in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings and asset management solutions. Our products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools and universities, hospitals and clinics, and more. Customers include contract cleaners to whom organizations outsource facilities maintenance, as well as businesses that perform facilities maintenance themselves. The Company reaches these customers through the industry's largest direct sales and service organization and through a strong and well-supported network of authorized distributors worldwide.

### Impact of COVID-19

Because we are a global company, our results of operations are affected by macroeconomic conditions. We continue to see economic and geopolitical uncertainty in many regions around the world. The coronavirus (COVID-19) pandemic has increased the uncertainty globally and has resulted in general economic disruption. Governments across the world have taken numerous actions to limit the spread of COVID-19, including stay-at-home orders, which have reduced operating activities across global businesses.

To date, the primary impact of the pandemic on the Company’s business has been related to a slowdown in sales to some end markets amid widespread closures of customer facilities and operations. We have experienced, and expect to continue experiencing, lower demand and volume for our products, including delivery and shipping delays that adversely impact our businesses. During the first quarter of 2020, we recorded quarter-to-date organic sales growth of 6.7% in February and a 16.8% decline in the month of March, compared to the respective prior year periods. In addition, during the second quarter of 2020, we experienced an organic sales decline of 27.2%. During the third quarter of 2020, we experienced an organic sales decline of 7.1%. We believe most of the organic sales decline in the second and third quarters of 2020 was due to the pandemic. We are unsure whether or not this level of decline, or if the trend in the sales decline on a quarter-to-quarter basis, will continue in the future.

We are actively managing our business to respond to the COVID-19 impact. We have prioritized the health and safety of our employees and customers. We have established a dedicated enterprise-wide response team and implemented work-from-home processes for much of our workforce. We have established cross-functional and daily communications with suppliers to review, track and prioritize high-risk components. We have also identified and activated alternative suppliers, materials and components as needed. To date, we have been able to avoid major supply disruptions. Regarding transportation, we have set up tracking, reporting and communication channels with carriers to understand their risks and to evaluate available options where necessary. For the majority of the second and third quarters of 2020, there were a limited number of restrictions on our manufacturing operations. Although end market demand was significantly lower than the same period last year, all of our factories had the ability to operate at full capacity.

We have also taken a number of actions globally to minimize the financial impact such as suspending a significant amount of business-related travel, reducing non-essential discretionary and project spending, applying for government wage subsidies and implementing merit freezes, hiring freezes, and other headcount-related actions, including a combination of salary cuts, reduced work schedules and/or furlough programs for all employees globally, while operating within the local laws and regulations, and developing multiple financial scenarios to ensure liquidity and to identify additional actions, if needed.

We continue to monitor the continuously evolving situation and guidance from authorities. As a result of the disruptions and volatility caused by COVID-19, we cannot reasonably estimate the long-term impact of the pandemic on our financial results. We expect that the longer the period of disruption continues, the more material the adverse impact will be on our business operations, financial performance and results of operations. Refer to Part II, Item 1A “Risk Factors” for an updated risk factor related to the COVID-19 pandemic.

### Historical Results

The following table compares the historical results of operations for the three and nine months ended September 30, 2020 and 2019, respectively, and as a percentage of Net Sales (in millions, except per share data and percentages):

|  | Three Months Ended September 30 |  | Nine Months Ended September 30 |  |
| --- | ---: | ---: | ---: | ---: |
|  | **2020%** | **2019%** | **2020%** | **2019%** |
| Net Sales | $261.9 100.0 | $280.7 100.0 | $728.0 100.0 | $842.8 100.0 |
| Cost of Sales | 157.1 60.0 | 166.7 59.4 | 428.5 58.9 | 499.8 59.3 |
| Gross Profit | 104.8 40.0 | 114.0 40.6 | 299.5 41.1 | 343.0 40.7 |
| Operating Expense: |  |  |  |  |
| Research and Development Expense | 7.4 2.8 | 8.2 2.9 | 21.4 2.9 | 23.8 2.8 |
| Selling and Administrative Expense | 79.0 30.2 | 84.3 30.0 | 222.4 30.5 | 267.0 31.7 |
| Total Operating Expense | 86.4 33.0 | 92.5 33.0 | 243.8 33.5 | 290.8 34.5 |
| Profit from Operations | 18.4 7.0 | 21.5 7.7 | 55.7 7.7 | 52.2 6.2 |
| Other Income (Expense): |  |  |  |  |
| Interest Income | 0.8 0.3 | 0.8 0.3 | 2.5 0.3 | 2.5 0.3 |
| Interest Expense | (5.2) (2.0) | (5.2) (1.9) | (15.9) (2.2) | (15.7) (1.9) |
| Net Foreign Currency Transaction Loss | (0.9) (0.3) | (0.6) (0.2) | (5.0) (0.7) | (0.6) (0.1) |
| Other (Expense) Income, Net | (0.2) (0.1) | 0.1 — | (0.2) — | 1.4 0.2 |
| Total Other Expense, Net | (5.5) (2.1) | (4.9) (1.7) | (18.6) (2.6) | (12.4) (1.5) |
| Profit Before Income Taxes | 12.9 4.9 | 16.6 5.9 | 37.1 5.1 | 39.8 4.7 |
| Income Tax Expense | 1.2 0.5 | 2.0 0.7 | 5.9 0.8 | 5.0 0.6 |
| Net Earnings Including Noncontrolling Interest | 11.7 4.5 | 14.6 5.2 | 31.2 4.3 | 34.8 4.1 |
| Net Earnings Attributable to Tennant Company | $11.7 4.5 | $14.6 5.2 | $31.2 4.3 | $34.8 4.1 |
| Net Earnings Attributable to Tennant Company per Share - Diluted | $0.63 | $0.79 | $1.68 | $1.89 |

23

### Net Sales

Consolidated Net Sales for the third quarter of 2020 totaled $261.9 million, a 6.7% decrease as compared to consolidated Net Sales of $280.7 million in the third quarter of 2019. Consolidated Net Sales for the first nine months of 2020 totaled $728.0 million, a 13.6% decrease as compared to consolidated Net Sales of $842.8 million in the first nine months of 2019.

The components of the consolidated Net Sales change for the three and nine months ended September 30, 2020 as compared to the same period in 2019 were as follows:

|  | 2020 v. 2019 Three Months Ended September 30 | Nine Months Ended September 30 |
| --- | ---: | ---: |
| Organic Net Sales | (7.1%) | (12.8%) |
| Foreign Currency | 0.4% | (0.8%) |
| Total Net Sales | (6.7%) | (13.6%) |

The 6.7% decrease in consolidated Net Sales in the third quarter of 2020 as compared to the same period in 2019 was driven by:

- An organic sales decrease of approximately 7.1%, which excludes the effects of foreign currency exchange. The organic sales decrease was due to volume declines across all regions, largely driven by the impact of the COVID-19 pandemic. The decrease was partially offset by continued strong demand for our autonomous cleaning machines in North America; and
- A favorable impact from foreign currency exchange of approximately 0.4%.

The 13.6% decrease in consolidated Net Sales in the first nine months of 2020 as compared to the same period in 2019 was driven by:

- An organic sales decrease of approximately 12.8%, which excludes the effects of foreign currency exchange. The organic sales decrease was primarily due to volume declines across all regions, largely driven by the impact of the COVID-19 pandemic. The decrease was partially offset by continued strong demand for our autonomous cleaning machines in North America; and
- An unfavorable impact from foreign currency exchange of approximately 0.8%.

The following table sets forth the Net Sales by geographic area for the three and nine months ended September 30, 2020 and 2019 and the percentage change from the prior year (in millions, except percentages):

|  | Three Months Ended September 30 |  | Nine Months Ended September 30 |  |
| --- | ---: | ---: | ---: | ---: |
|  | **2020** | **2019%** | **2020** | **2019%** |
| Americas | $167.7 | $186.1 (9.9) | $466.6 | $536.4 (13.0) |
| Europe, Middle East and Africa | 69.5 | 69.7 (0.3) | 196.3 | 228.6 (14.1) |
| Asia Pacific | 24.7 | 24.9 (0.8) | 65.1 | 77.8 (16.3) |
| Total | $261.9 | $280.7 (6.7) | $728.0 | $842.8 (13.6) |

#### Americas

Net Sales in the Americas were $167.7 million for the third quarter of 2020, a decrease of 9.9% from the third quarter of 2019. Foreign currency exchange within the Americas unfavorably impacted Net Sales by approximately 1.1% in the third quarter of 2020. Organic sales declines in the Americas unfavorably impacted Net Sales by approximately 8.8% for the third quarter of 2020 particularly due to softness in direct industrial and distributor sales, partially offset by continued demand for our autonomous cleaning machines in North America and strong growth in Brazil.

Net Sales in the Americas were $466.6 million for the first nine months of 2020, a decrease of 13.0% from the first nine months of 2019. Foreign currency exchange within the Americas unfavorably impacted Net Sales by approximately 1.0% for the first nine months of 2020. Organic sales declines in the Americas unfavorably impacted Net Sales by approximately 12.0% for the first nine months of 2020 due to the impact of COVID-19 throughout the entire region, partially offset by continued demand for our autonomous cleaning machines in North America.

#### Europe, Middle East and Africa

EMEA Net Sales were $69.5 million for the third quarter of 2020, a decrease of 0.3% from the third quarter of 2019. Foreign currency exchange within EMEA favorably impacted Net Sales by approximately 4.2% in the third quarter of 2020. Organic sales declines in EMEA unfavorably impacted Net Sales by approximately 4.5% for the third quarter primarily due to market weakness across the region, especially in the United Kingdom and Iberian Peninsula, partially offset by growth in Italy and France.

EMEA Net Sales were $196.3 million for the first nine months of 2020, a decrease of 14.1% from the first nine months of 2019. Foreign currency exchange within EMEA unfavorably impacted Net Sales by approximately 0.4% in the first nine months of 2020. Organic sales declines in EMEA unfavorably impacted Net Sales by approximately 13.7% for the first nine months of 2020 primarily due to the impact of COVID-19 throughout the region.

#### Asia Pacific

APAC Net Sales were $24.7 million for the third quarter of 2020, a decrease of 0.8% from the third quarter of 2019. Foreign currency exchange within APAC favorably impacted Net Sales by approximately 1.5% in the third quarter of 2020. Organic sales declines in APAC unfavorably impacted Net Sales by approximately 2.3% for the third quarter, especially across Southeast Asia and Korea, partially offset by growth in Australia, particularly in the direct sales channel.

APAC Net Sales were $65.1 million for the first nine months of 2020, a decrease of 16.3% from the first nine months of 2019. Foreign currency exchange within APAC unfavorably impacted Net Sales by approximately 1.1% in the first nine months of 2020. Organic sales declines in APAC unfavorably impacted Net Sales by approximately 15.2% for the first nine months of 2020, primarily due to the impact of COVID-19 throughout the region, particularly in China and Japan.

### Gross Profit

Gross Profit margin of 40.0% was 60 basis points lower in the third quarter of 2020 compared to the third quarter of 2019. The decrease primarily reflects strategic investments in the business and volume deleverage, partially offset by cost-out initiatives related to the Company's enterprise strategy efforts.

Gross Profit margin of 41.1% was 40 basis points higher in the first nine months of 2020 compared to the first nine months of 2019. The increase was primarily driven by actions directly resulting from the Company’s enterprise strategy efforts like pricing and cost-out initiatives, benefits from government programs received related to COVID-19 and cost reduction actions, partially offset by volume deleverage, higher material costs, and strategic investments in the business. The government benefits included in Gross Profit in the first nine months of 2020 were $3.8 million and were substantially received in the second quarter of 2020. The benefits represent wage subsidies received from various European and Canadian authorities that are not required to be repaid.

### Operating Expense

#### Research and Development Expense

Research and Development ("R&D") Expense was $7.4 million, or 2.8% as a percentage of Net Sales, for the third quarter of 2020, essentially flat compared to the third quarter of 2019. R&D Expense was $21.4 million, or 2.9% as a percentage of Net Sales, for the first nine months of 2020, essentially flat compared to the first nine months of 2019.

We continue to invest in developing innovative products and technologies at levels necessary to propel our technology and innovation leadership position.

#### Selling and Administrative Expense

Selling and Administrative Expense ("S&A Expense") was $79.0 million for the third quarter of 2020, a decrease of $5.3 million compared to the third quarter of 2019. As a percentage of Net Sales, S&A Expense for the third quarter of 2020 increased 20 basis points to 30.2% from 30.0% in the third quarter of 2019. The S&A Expense decrease in the third quarter of 2020 was primarily driven by cost containment initiatives throughout the Company, including reduction in management incentives, travel costs and other discretionary spending. The decrease was partially offset by an acquisition contingent consideration adjustment which incurred in 2019 that did not repeat in 2020 as well as some investments in the business.

S&A Expense was $222.4 million for the first nine months of 2020, a decrease of $44.6 million compared to the first nine months of 2019. As a percentage of Net Sales, S&A Expense for the first nine months of 2020 decreased 120 basis points to 30.5% from 31.7% in the first nine months of 2019. S&A Expense in the first nine months of 2020 was primarily driven by cost containment initiatives throughout the Company, including employee furloughs, reduction in travel spending, and temporary pay reductions as well as benefits from government programs received related to COVID-19 and adjustments to management incentives. The government benefits included in S&A Expense in the first nine months of 2020 were $1.6 million and were substantially received in the second quarter of 2020. The benefits represent wage subsidies received from various European and Canadian authorities that are not required to be repaid. The remaining decrease included higher restructuring charges and a note receivable write-down as well as acquisition- and integration-related expenses incurred in 2019 that did not repeat in 2020.

### Total Other Expense, Net

#### Interest Income

Interest Income was $0.8 million in the third quarter of 2020 and 2019. For the first nine months of 2020 and 2019, Interest Income was $2.5 million.

#### Interest Expense

Interest Expense was $5.2 million in the third quarter of 2020 and 2019. For the first nine months of 2020, Interest Expense was $15.9 million, relatively flat compared to Interest Expense of $15.7 million in the first nine months of 2019.

#### Net Foreign Currency Transaction Loss

Net Foreign Currency Transaction Loss in the third quarter of 2020 was a loss of $0.9 million compared to a loss of $0.6 million in the third quarter of 2019. The unfavorable impact from foreign currency transactions in the third quarter of 2020 was primarily due to the strengthening of the U.S. dollar relative to the Brazilian real during those times.

For the first nine months of 2020, Net Foreign Currency Transaction Losses were $5.0 million compared to losses of $0.6 million in the first nine months of 2019. The change in the impact from foreign currency transactions in the first nine months of 2020 was primarily due to significant strengthening of the U.S. dollar relative to the Brazilian real and Mexican peso compared to the same period of last year.

#### Other (Expense) Income, Net

Other (Expense) Income, Net was $0.2 million in the third quarter and first nine months of 2020, a decrease of $0.3 million and $1.6 million compared to the same periods in 2019, respectively. The decrease was primarily due to a $1.8 million acquisition-related indemnification settlement in 2019.

### Income Taxes

The effective tax rate for the third quarter of 2020 was 9.7%, as compared to the third quarter of 2019 of 12.2%. The tax expense for the third quarter 2020 and 2019 included a $0.4 million tax benefit associated with $1.7 million of non-recurring expenses and a $0.1 million tax benefit associated with $2.8 million of non-recurring expenses, respectively, which impacted the effective tax rate by (1.6)% and (3.9)%, respectively.

Excluding these special items, the third quarter effective tax rate decreased primarily due to an increase in recognized discrete tax benefit items and the mix in expected full year taxable earnings by country.

The year-to-date effective tax rate was 15.9% for 2020 compared to 12.5% for 2019. The tax expense for the nine months ended September 30, 2020 and September 30, 2019 included a $1.2 million tax benefit associated with $4.1 million of non-recurring expenses and a $2.4 million tax benefit associated with $9.2 million of non-recurring expenses, respectively, which impacted the effective tax rate by (1.3%) and (2.7%), respectively.

Excluding these special items, the year-to-date effective tax rate was higher primarily due to a decrease in recognized discrete tax benefit items and the mix in expected full year taxable earnings by country.

In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is zero or immaterial. No deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of our foreign investments to the United States.

### Liquidity and Capital Resources

#### Liquidity

Cash, Cash Equivalents and Restricted Cash totaled $124.7 million at September 30, 2020, as compared to $74.6 million as of December 31, 2019. Wherever possible, cash management is centralized and intercompany financing is used to provide working capital to subsidiaries as needed. At the end of March 2020, we borrowed $125 million from our revolving credit line as a precaution to ensure we would be able to cover our cash requirements if the COVID-19 pandemic were to continue for an extended period of time. In the second quarter of 2020, we repaid the entire $125 million borrowed in March 2020 as we determined our existing cash and cash flows were sufficient for our business needs. Our current ratio was 2.0 and 1.7 as of September 30, 2020 and December 31, 2019, respectively, and our working capital was $247.0 million and $206.1 million, respectively. Our debt-to-capital ratio was 45.1% as of September 30, 2020, compared to 48.5% as of December 31, 2019.

#### Cash Flow From Operating Activities

Operating Activities provided $97.5 million of cash for the nine months ended September 30, 2020. Cash provided by operating activities was driven primarily by inflows from Net Earnings adding back non-cash items of $77.1 million, a decrease in Accounts Receivables of $23.4 million, and a decrease in Inventories of $13.1 million. These cash inflows were partially offset by cash outflows resulting from a decrease in Accounts Payables of $7.8 million and a decrease in our Employee Compensation and Benefits liabilities of $11.9 million, primarily related to 2019 incentive payments to employees.

#### Cash Flow From Investing Activities

Investing activities during the nine months ended September 30, 2020 used $25.5 million, substantially all of which related to net capital expenditures.

#### Cash Flow From Financing Activities

Net cash used in financing activities was $24.5 million during the first nine months of 2020. Proceeds from borrowings of $126.4 million and proceeds from the issuance of Common Stock of $3.6 million were offset by payment of credit facility borrowings of $142.3 million and dividend payments of $12.1 million.

### Newly Issued Accounting Guidance

See Note 2 to the Consolidated Financial Statements for information on new accounting pronouncements.

No other new accounting pronouncements issued but not yet effective have had, or are expected to have, a material impact on our results of operations or financial position.

### Cautionary Statement Relevant to Forward-Looking Information

This Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “project,” or “continue” or similar words or the negative thereof. These statements do not relate to strictly historical or current facts and provide current expectations of forecasts of future events. Any such expectations or forecasts of future events are subject to a variety of factors. Particular risks and uncertainties presently facing us include: uncertainty surrounding the impacts and duration of the COVID-19 pandemic; our ability to effectively develop or manage strategic planning and growth processes; our ability to successfully upgrade and evolve our information technology systems; fluctuations in the cost, quality, or availability of raw materials and purchased components; geopolitical and economic uncertainty throughout the world; our ability to integrate acquisitions; our ability to attract, retain and develop key personnel and create effective succession planning strategies; our ability to successfully protect our information technology systems from cybersecurity risks; our ability to develop and commercialize new innovative products and services; the occurrence of a significant business interruption; our ability to comply with laws and regulations; the potential disruption of our business from actions of activist investors or others; the competition in our business; unforeseen product liability claims or product quality issues; our ability to generate sufficient cash to satisfy our debt obligations; and the relative strength of the U.S.

dollar, which affects the cost of our materials and products purchased and sold internationally. We caution that forward-looking statements must be considered carefully and that actual results may differ in material ways due to risks and uncertainties both known and unknown. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Additional information about factors that could materially affect our results can be found in Part I, Item 1A, Risk Factors in our annual report on Form 10-K for the year ended December 31, 2019 and Part II, Item 1A of this Form 10-Q.

We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Investors are advised to consult any further disclosures by us in our filings with the SEC and in other written statements on related subjects. It is not possible to anticipate or foresee all risk factors, and investors should not consider any list of such factors to be an exhaustive or complete list of all risks or uncertainties.

## Market risk

As filed, 196 characters.

There have been no material changes in our market risk since December 31, 2019. For additional information, refer to Item 7A of our annual report on Form 10-K for the year ended December 31, 2019.

## Controls and procedures

As filed, 1,271 characters.

#### Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2020 (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)). Based on that evaluation, our Chief Executive Officer and our Principal Financial and Accounting Officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive and our principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.

#### Changes in Internal Controls

There were no changes in our internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 2,099 characters.

Other than the risk set out below, there have been no material changes to our risk factors in Item 1A of Part I of our annual report on Form 10-K for the fiscal year ended December 31, 2019.

### Uncertainty surrounding the impacts and duration of the COVID-19 pandemic

The coronavirus ("COVID-19") outbreak that originated in China at the beginning of 2020 continues to cause volatility and economic disruption across the globe. The impact of COVID-19 on our business and financial performance depends on evolving factors that we cannot accurately predict, including the duration of the pandemic, restrictions on travel and transportation, the effect on our customers and on the global supply chain, the demand for our products, government actions that have or could result in further closures of or restrictions on our manufacturing plants, and the pace of economic recovery when the COVID-19 pandemic subsides.

Certain of our manufacturing plants previously suspended operations temporarily either due to government restrictions or employee health concerns. There may be a risk of future health concerns and we cannot predict future disruptions of our plants or how long they would last.

Our customers have been negatively impacted which has had, and may continue to have, a material adverse impact on our sales. In addition, our suppliers may not have the ability to provide us with parts needed to manufacture our products. This may result in delays in shipments to us and also to our customers, which would affect our results of operations.

If the pandemic continues for a long duration, we will need to assess our liquidity needs. A sustained disruption in the global economy could materially affect our ability to generate sufficient cash from operations and could require us to seek additional sources of liquidity or take further actions. It could also impact our ability to meet our strategic objectives.

As a result of the COVID-19 pandemic, our risk factors previously disclosed in our annual report on Form 10-K for the fiscal year ended December 31, 2019 have also been heightened.

Filed Oct 29, 2020.
Source: SEC EDGAR, the filing index for accession 0000097134-20-000042. Last ingested by Listed: Nov 5, 2026, 14:03 ET. No prices; not investment advice.
